EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Postcommercialisation outcomes of bridge‐enhanced anterior cruciate ligament restoration: The first 100 Bridge registry patients

Jocelyn Wittstein iD, Sabrina Strickland iD, Andreas Gomoll iD, Seth Sherman iD, Brian Lau iD, Dean Taylor iD, Dennis Kramer iD, Sean Keyes iD, Alexander K Meininger iD, Marc Pietropaoli, Sean McMillan iD, Daryl Osbahr iD und 1 weitere

Knee Surgery, Sports Traumatology, Arthroscopy · 2026-06 · 34 (6) · 2013-2024

DOI: 10.1002/ksa.12806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Knee Surgery, Sports Traumatology, Arthroscopy, online erschienen am 13.08.2025. Verfasst von Jocelyn Wittstein und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Anterior Cruciate Ligament Reconstruction, Anterior Cruciate Ligament Injuries. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Miach Orthopaedics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To review adverse events and outcomes at least 1 year postoperatively from Bridge enhanced ACL restoration (BEAR) in the first 100 subjects of the Bridge registry, a postcommercialisation prospective cohort.

Methods

Consecutive BEAR patients were invited to enroll in the Bridge registry. Technique modifications, adverse events and reoperations were recorded. Physical examinations and patient reported outcomes (International Knee Documentation Committee [IKDC], knee injury and osteoarthritis outcome score [KOOS], Marx and return to sport index [RSI]) were reported at 0, 6, 9 and 12 months.

Results

Of the 100 subjects, 94 enrolled postoperatively. Four exited the study. Mean follow up was 15.3 ± 4.7 months. The mean age was 31.3 ± 14.3 years. 67% were female. Classic and modified techniques were each used in 50 cases. The rates of adverse events and reoperations at 1 year were: one deep venous thrombosis, two meniscal injuries without anterior cruciate ligament (ACL) retear and eight reoperations (one debridement, two manipulations, three suture removals, one partial lateral meniscectomy and one medial meniscus repair). Adverse events between 1 and 2 years included one recurrent ACL tear with associated meniscus tears, two meniscal injuries without ACL tear, and one isolated ACL tear. Overall reoperation rate was 8.3% (8/96) at 1 year and 11.5% (11/96) at final follow‐up, with 0% ACL retear at 1 year and 2.1% (2/96) ACL retear at final follow‐up. Mean IKDC, Marx and RSI scores at 12 months were ( N = 79), respectively 82.7 ± 14.6, 7.5 ± 5.36 and 66.6 ± 24.06. Mean KOOS pain, function daily living and function sports and recreational activities were: 92.7 ± 8.6, 96.7 ± 6.0 and 82.0 ± 18.5. Lachman ( N = 75) was 0–2 mm in 80.0% (60/75) and 3–5 mm in 20.0% (15/75). Pivot shift ( N = 73) was negative in 90.4% (66/73), grade 1 in 8.2% (6/73) and grade 2 in 1.4% (1/73) at 12 months.

Conclusion

The rates of adverse events of BEAR with and without modification are low at 1 year. Excellent stability and ROM are attained at 1 year. Clinical Relevance BEAR has promising results in postcommercial utilization and is as an alternative to reconstruction. Level of Evidence Level II cohort study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anterior Cruciate Ligament ReconstructionAnterior Cruciate Ligament InjuriesHumansFemaleRegistriesAdultReoperationProspective StudiesMaleYoung AdultTreatment OutcomeReturn to SportAdolescentMiddle AgedPostoperative ComplicationsFollow-Up StudiesTibial Meniscus Injuries

Stichwörter der Autor:innen

ACL reconstructionACL repairACL retearBEARknee

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
  • Sports Medicine Institute, Hospital for Special Surgery, New York, New York, USA.
  • Stanford University, Redwood City, California, USA.
  • Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • AdventHealth, Orlando, Florida, USA.
  • Steamboat Orthopaedic & Spine Institute, Steamboat Springs, Colorado, USA.

ORCID-Profile: Jocelyn Wittstein, Sabrina Strickland, Andreas Gomoll, Seth Sherman, Brian Lau, Dean Taylor, Dennis Kramer, Sean Keyes, Alexander K Meininger, Sean McMillan, Daryl Osbahr, Jacqueline Brady

Förderung

  • Miach Orthopaedics

Zitieren

APA

Wittstein, J., Strickland, S., Gomoll, A., Sherman, S., Lau, B., Taylor, D., Kramer, D., Keyes, S., Meininger, A. K., Pietropaoli, M., McMillan, S., Osbahr, D., & Brady, J. (2026). Postcommercialisation outcomes of bridge‐enhanced anterior cruciate ligament restoration: The first 100 Bridge registry patients. Knee Surgery, Sports Traumatology, Arthroscopy, 34(6), 2013-2024. https://doi.org/10.1002/ksa.12806

Vancouver

Wittstein J, Strickland S, Gomoll A, Sherman S, Lau B, Taylor D, et al. Postcommercialisation outcomes of bridge‐enhanced anterior cruciate ligament restoration: The first 100 Bridge registry patients. Knee Surgery, Sports Traumatology, Arthroscopy. 2026;34(6):2013-2024. doi:10.1002/ksa.12806

BibTeX
@article{Wittstein2026,
  author = {Wittstein, Jocelyn and Strickland, Sabrina and Gomoll, Andreas and Sherman, Seth and Lau, Brian and Taylor, Dean and Kramer, Dennis and Keyes, Sean and Meininger, Alexander K and Pietropaoli, Marc and McMillan, Sean and Osbahr, Daryl and Brady, Jacqueline},
  title = {Postcommercialisation outcomes of bridge‐enhanced anterior cruciate ligament restoration: The first 100 Bridge registry patients},
  journal = {Knee Surgery, Sports Traumatology, Arthroscopy},
  year = {2026},
  volume = {34},
  number = {6},
  pages = {2013--2024},
  doi = {10.1002/ksa.12806}
}
Kostenlos starten →